Flagship Harbor Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-31
Closed -$5.08K – 1846
2025
Q4
$5.08K Buy
+31
New +$4.86K ﹤0.01% 1656
2020
Q4
– Sell
-544
Closed -$80K – 1481
2020
Q3
$80K Buy
544
+18
+3% +$2.57K 0.01% 719
2020
Q2
$65K Buy
526
+150
+40% +$17.6K 0.01% 778
2020
Q1
$36K Hold
376
– – 0.01% 852
2019
Q4
$35K Hold
376
– – 0.01% 920
2019
Q3
$28K Buy
376
+110
+41% +$9.62K 0.01% 978
2019
Q2
$22K Buy
266
+66
+33% +$4.5K ﹤0.01% 1039
2019
Q1
$11K Hold
200
– – ﹤0.01% 1275
2018
Q4
$10K Hold
200
– – ﹤0.01% 1231
2018
Q3
$11K Hold
200
– – ﹤0.01% 1386
2018
Q2
$9K Buy
+200
New +$8.23K ﹤0.01% 1431

Other funds holding RGEN

Flagship Harbor Advisors's RGEN Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Repligen (RGEN) in Q1 2026, closing a stake of 31 shares — an estimated $5.08K sold.

Flagship Harbor Advisors first reported a position in RGEN in Q2 2018 and held it in 11 quarters. The position peaked at $80K in Q3 2020. 445 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 31 Repligen shares in Q1 2026, an estimated $5.08K.
  • Flagship Harbor Advisors first reported a position in Repligen in Q2 2018 and held it in 11 quarters.
  • Flagship Harbor Advisors's Repligen position peaked at $80K in Q3 2020.
  • 445 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.